Reversal of pathological pain through specific spinal GABAA receptor subtypes
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Inflammatory diseases and neuropathic insults are frequently accompanied by severe and debilitating pain, which can become chronic and often unresponsive to conventional analgesic treatment. A loss of synaptic inhibition in the spinal dorsal horn is considered to contribute significantly to this pain pathology. Facilitation of spinal gamma-aminobutyric acid (GABA)ergic neurotransmission through modulation of GABA(A) receptors should be able to compensate for this loss. With the use of GABA(A)-receptor point-mutated knock-in mice in which specific GABA(A) receptor subtypes have been selectively rendered insensitive to benzodiazepine-site ligands, we show here that pronounced analgesia can be achieved by specifically targeting spinal GABA(A) receptors containing the alpha2 and/or alpha3 subunits. We show that their selective activation by the non-sedative ('alpha1-sparing') benzodiazepine-site ligand L-838,417 (ref. 13) is highly effective against inflammatory and neuropathic pain yet devoid of unwanted sedation, motor impairment and tolerance development. L-838,417 not only diminished the nociceptive input to the brain but also reduced the activity of brain areas related to the associative-emotional components of pain, as shown by functional magnetic resonance imaging in rats. These results provide a rational basis for the development of subtype-selective GABAergic drugs for the treatment of chronic pain, which is often refractory to classical analgesics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, in contrast to morphine, no analgesic tolerance occurred in rats after a 9-day treatment with the α 2/3 subtype GABAA receptor positive allosteric modulator L838,417 using a model of neuropathic pain [157].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [157]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Melzack, R., & Wall, P. D. (1965) · Science · doi:10.1126/science.150.3699.971 · Cited by 11,090
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
Bennett, G. J., & Xie, Y.-K. (1988) · Pain · doi:10.1016/0304-3959(88)90209-6 · Cited by 5,376
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135
Neuronal plasticity: Increasing the gain in pain
Woolf, C. J., & Salter, M. W. (2000) · Science · doi:10.1126/science.288.5472.1765 · Cited by 3,781
Dubuisson, D., & Dennis, S. G. (1977) · Pain · doi:10.1016/0304-3959(77)90130-0 · Cited by 2,524
RARE imaging: A fast imaging method for clinical MR
Hennig, J., Nauerth, A., & Friedburg, H. (1986) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910030602 · Cited by 2,081
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
Coull, J. A. M., Beggs, S., Boudreau, D., Boivin, D., Tsuda, M., Inoue, K., Gravel, C., Salter, M. W., & De Koninck, Y. (2005) · Nature · doi:10.1038/nature04223 · Cited by 1,965
Cited by
Items 301–400 of 441
Qi, W., Fu, H., Luo, X., Ren, Y., Liu, X., Dai, H., Zheng, Q., & Liang, F. (2022) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-022-10245-w · Cited by 10
“GABAA receptor activation, results in decreases in the release of excitatory neurotransmitters, which plays an inhibitory role to reduce the transmission of pain signals [46].”
BackgroundMechanisms of Plasticity of Inhibition in Chronic Pain Conditions
Labrakakis, C., Ferrini, F., & Koninck, Y. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6978-1_7 · Cited by 9
Pain in Huntington’s disease and its potential mechanisms
Li, J., Wang, Y., Yang, R., Ma, W., Yan, J., Li, Y., Chen, G., & Pan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1190563 · Cited by 12
Multiple actions of fenamates and other nonsteroidal anti-inflammatory drugs on GABAA receptors
Mansikkamäki, S., Sinkkonen, S. T., Korpi, E. R., & Lüddens, H. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.039 · Cited by 8
Receptor and Channel Heteromers as Pain Targets
Berg, K. A., Patwardhan, A. M., & Akopian, A. N. (2012) · Pharmaceuticals · doi:10.3390/ph5030249 · Cited by 9
“Using these mice, it was demonstrated that the spinal antihyperalgesic effects of diazepam were mediated mainly through GABAA channels containing 2, but not 1, 3 and 5 subunits [115,116].”
BackgroundPapon, M.-A., Feuvre, Y. L., Barreda‐Gómez, G., Favereaux, A., Farrugia, F., Bouali‐Benazzouz, R., Nagy, F., Rodríguez‐Puertas, R., & Landry, M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00214 · Cited by 9
Acute neurosteroids inhibit the spinal reflex potentiation via GABAergic neurotransmission
Chang, J.-L., Peng, H., Wu, H., Lu, H.-T., Pan, S.-F., Chen, M.-J., & Lin, T.-B. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00632.2009 · Cited by 9
Refinement and reduction in animal experimentation: Options for new imaging techniques
Heindl, C., Heß, A., & Brune, K. (2008) · ALTEX · doi:10.14573/altex.2008.2.121 · Cited by 10
“The results displayed are comparable to the data shown in Knabl et al., 2008.”
BackgroundResultSelf-citationLewter, L. A., Woodhouse, K. L., Tiruveedhula, V. V. N. P. B., Cook, J. M., & Li, J. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.002070 · Cited by 8
Rong, W., Qian, X., Yin, Y., Gu, Y., Su, W., Li, J., Xu, Y., Zhu, H., Li, J., & Zhu, Q. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70197 · Cited by 8
Peripheral and central sensitization
Toth, C. C. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139152211.006 · Cited by 16
Guerrini, G., Ciciani, G., Crocetti, L., Daniele, S., Ghelardini, C., Giovannoni, M. P., Mannelli, L. D. C., Martini, C., & Vergelli, C. (2017) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.2882 · Cited by 7
Natural product incarvillateine aggravates epileptic seizures by inhibiting GABAA currents
Bian, X., Zhang, Y., Huang, B., Wang, X., Wang, G., Zhu, Y., Liu, Y., Liang, J., Jia, Y., & Wang, K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172496 · Cited by 8
Heidelberg, L. S., Warren, J., & Fisher, J. L. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.207324 · Cited by 7
“…least part of the anxiolytic, analgesic, myorelaxant, and anesthetic effects of GABA-modulating drugs (Rudolph and Mohler, 2004; Dias et al., 2005; Knabl et al., 2008; Straub et al., 2013), and deficits in signaling through a3-containing receptors have been linked to disruption of sensorimotor…”
BackgroundSöderhielm, P. C., Balle, T., Bak-Nyhus, S., Zhang, M., Hansen, K. M., Ahring, P. K., & Jensen, A. A. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.019 · Cited by 7
Neutral sphingomyelinase controls acute and chronic alcohol effects on brain activity
Wank, I., Mittmann, C., Kreitz, S., Chestnykh, D., Mühle, C., Kornhuber, J., Ludwig, A., Kalinichenko, L. S., Müller, C. P., & Heß, A. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109948 · Cited by 7
“Further analyses, including FFT low pass filtering at 0.1 Hz to remove physiological noise, were performed using MagnAn (BioCom GbR, Uttenreuth, Germany) written in IDL (L3Harris Geospatial, Broomfield, CO, USA) (Knabl et al., 2008).”
InfluentialPerspectives and Trends in Pharmacological Approaches to the Modulation of Pain
Barrett, J. E., & Haas, D. A. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2015.12.004 · Cited by 8
Do MicroRNAs Modulate Visceral Pain?
Tao, Z.-Y., Yang, X. W., Li, J., Traub, R. J., & Cao, D. (2018) · BioMed Research International · doi:10.1155/2018/5406973 · Cited by 7
Zeilhofer, H. U., & Ganley, R. P. (2019) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190860509.013.23 · Cited by 6
Self-citationРедер, А. С., Ларіонов, В. Б., & Golovenko, M. Y. (2022) · EUREKA Health Sciences · doi:10.21303/2504-5679.2022.002649 · Cited by 6
Krotov, V., Agashkov, K., Romanenko, S., Halaidych, O., Andrianov, Y., Safronov, B. V., Belan, P. V., & Voitenko, N. V. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1029799 · Cited by 8
“Non-synaptic AD-PI mechanisms may involve GABAA receptors, expressed in the central axons and terminals of thin afferents (Knabl et al., 2008; Witschi et al., 2011; Paul et al., 2012; Lorenzo et al., 2014).”
BackgroundMannewitz, A., Bock, J., Kreitz, S., Hess, A., Goldschmidt, J., Scheich, H., & Braun, K. (2018) · Brain Structure and Function · doi:10.1007/s00429-017-1605-x · Cited by 7
Self-citationMatthey, A., Daali, Y., Curtin, F., Poncet, A., Desmeules, J. A., & Besson, M. J. (2020) · European Journal of Pain · doi:10.1002/ejp.1554 · Cited by 6
“Antihyperalgesic effects of several selective positive allosteric modulators (GAMs) of GABAA receptors are demonstrated in rodents (Di Lio et al., 2011; Knabl et al., 2008; Zeilhofer, Mohler, & Di Lio, 2009).”
BackgroundPrevention and Reversal of Morphine Tolerance by the Analgesic Neuroactive Steroid Alphadolone
Goodchild, C. S., Kolosov, A., Geng, L., Winter, L., & Nadeson, R. (2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00663.x · Cited by 6
Neuropathische Schmerzen: Pathophysiologie, Diagnostik und Therapie
Sommer, C. (2013) · Der Schmerz · doi:10.1007/s00482-013-1344-8 · Cited by 7
Spinal GABAA receptors for pain control—lost in translation?
Zeilhofer, H. U., Neumann, E., & Munro, G. (2018) · Pain · doi:10.1097/j.pain.0000000000001268 · Cited by 5
Self-citationDuhaldea pterocaula (Franch.) Anderb. Attenuates Nociception and Inflammation via GABAA Receptors
Huang, C., Dong, C., Zhu, Y., Yu, Y., Jin, H., & Zhang, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.753128 · Cited by 6
“Considerable evidence supported that facilitating GABAergic inhibition was able to reverse pathological pain states in mice and also pointed to the associations between GABAAR and inflammatory disorders in brain and peripheral organs; GABA was able to decrease the proinflammatory mediator production and ameliorate inf…”
BackgroundWank, I., Kutsche, L. K., Kreitz, S., Reeh, P. W., & Heß, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266669 · Cited by 6
Pizaña-Encarnación, J. M., Escoto-Rosales, M. J., Islas-Espinoza, A. M., Morales-Galindo, D. K., Déciga‐Campos, M., Quintanar, B. G., Reyes, R., Granados‐Soto, V., & Fernández‐Guasti, A. (2025) · Hormones and Behavior · doi:10.1016/j.yhbeh.2025.105746 · Cited by 4
Borneol’s Pre-Clinical Analgesic Efficacy: Mediated by Receptor and Immune Mechanisms
Zhou, Y., Mei, X., & Wang, C. (2025) · Journal of Pain Research · doi:10.2147/jpr.s533901 · Cited by 5
“54,55 Research has demonstrated that (+)-borneol functions as a full agonist of GABAA receptors.”
Ding, T., Zhang, L., Xu, J., Liu, M., Ouyang, Y., & Liu, S. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111625 · Cited by 4
Shahid, M., Subhan, F., Ahmad, N., Din, Z. U., Ullah, I., Rahman, S. U., Ullah, R., Farooq, U., Alam, J., Nawaz, N. U. A., et al. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150217 · Cited by 4
Chu, X., Wu, J.-H., Yu, H., Chun-Ge, Liu, Y.-X., Zou, J., & Li, J. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110317 · Cited by 4
Novel aspects of signal processing in lamina I
Safronov, B. V., & Szűcs, P. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109858 · Cited by 4
“The spinal branches and terminals of peptidergic and nonpeptidergic C-fibers express GABA A receptors (Knabl et al., 2008; Witschi et al., 2011; Paul et al., 2012; Lorenzo et al., 2014) that are not associated with synapses and can be activated by volume transmission.”
Xia, M., Wang, T., Wang, Y., Hu, T., Chen, D., & Wang, B. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1436059 · Cited by 4
Huang, Y., Rui-Jia, G. A. O., Mao, S., Jin-Liang, Y. A. O., He, H., Ying, W. A. N. G., & Feng, J. (2025) · Minerva Anestesiologica · doi:10.23736/s0375-9393.24.18563-x · Cited by 5
Whiplash Associated Disorders (WAD): Responses to pharmacological challenges and psychometric tests
Persson, M., Sörensen, J., & Gerdle, B. U. C. (2012) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2012.01.003 · Cited by 4
Graham, B. A., & Callister, R. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-369497-3.10023-8 · Cited by 4
Flavonoids in neuropathic pain management: A new player on an old target
Akbar, S. (2019) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp2019.5023 · Cited by 4
Lewter, L. A., Golani, L. K., Cook, J. M., & Li, J. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000614 · Cited by 5
“Additionally, pharmacological studies have shown that α1-sparing GABA A PAMs produce robust antihyperalgesia devoid of analgesic tolerance (Knabl et al., 2008; Di Lio et al., 2011).”
BackgroundPain-processing mechanisms in whiplash associated disorders
Curatolo, M., & Sterling, M. M. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7295-3946-3.10005-3 · Cited by 5
Spinal neuroplasticity in chronic pain
Zeilhofer, H. U. (2011) · e-Neuroforum · doi:10.1007/s13295-011-0018-1 · Cited by 4
Self-citationClément, Y., Prut, L., Saurini, F., Mineur, Y. S., Guisquet, A. M. L., Védrine, S., Andres, C. R., Vodjdani, G., & Belzung, C. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.05.041 · Cited by 5
Etifoxine (Stresam®) for chemotherapy-induced pain?
Zeilhofer, H. U. (2009) · Pain · doi:10.1016/j.pain.2009.09.021 · Cited by 4
“Both of these actions, direct activation or neurosteroid-mediated facilitation of GABA-A receptors, could underlie the analgesic effect of etifoxine, especially as peripheral nerve damage has been shown to reduce GABAergic inhibition [3] and drugs that potentiate spinal GABAA receptors alleviate neuropathic pain [7].”
BackgroundSelf-citationMedical, pharmacological and neurosurgical perspectives on trigeminal neuralgia
Dexter, M., & Aggarwal, A. K. (2018) · Australian Endodontic Journal · doi:10.1111/aej.12255 · Cited by 4
Fast Inhibitory Transmission of Pain in the Spinal Cord
Zeilhofer, H. U., Witschi, R., & Johansson, T. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0226-9_3 · Cited by 5
“Shortly after birth, mixed GABAergic and glycinergic miniature IPSCs, which indicate co-release of both transmitters from a single vesicle, occur frequently, but become less frequent during development and disappear completely by P30 (at least in laminae I and II) ( Keller et al., 2001 ).”
BackgroundInfluentialSelf-citationγ1 GABAAReceptors in Spinal Nociceptive Circuits
Neumann, E., Cramer, T. L. M., Acuña, M. A., Scheurer, L., Beccarini, C., Lüscher, B., Wildner, H., & Zeilhofer, H. U. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.0591-24.2024 · Cited by 3
“Potentiation of GABAergic inhibition at this site is antihyperalgesic in di ff erent animal models of in fl ammatory and neuropathic pain (Knabl et al., 2008, 2009; Di Lio et al., 2011; Braz et al., 2012; Reichl et al., 2012; Ralvenius et al., 2015; Neumann et al., 2021).”
BackgroundInfluentialSelf-citationLiu, X., Krezel, M., & Wang, W. (2025) · Nature Communications · doi:10.1038/s41467-025-60516-8 · Cited by 5
14-3-3ζ Mediates GABAAR Activation by Interacting with BIG1
Li, C., Huang, S., Peng, J., Hong, T., Zhou, C., & Tang, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03172-z · Cited by 3
Initial validation of the expectancies for Benzodiazepine Analgesia Scale.
Lape, E. C., Powers, J. M., LaRowe, L. R., & Ditre, J. W. (2023) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000692 · Cited by 4
Disha, I. J., Hasan, R., Bhuia, M. S., Ansari, S. A., Ansari, I. A., & Islam, M. T. (2024) · ChemistryOpen · doi:10.1002/open.202400290 · Cited by 4
Karim, N., Khan, I., Abdelhalim, A., Halim, S. A., Khan, A., Altaf, N., Ahmad, W., Ghaffar, R., & Al‐Harrasi, A. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-02021-x · Cited by 3
Pharmakologische Aspekte der Schmerzforschung in Deutschland
Niederberger, E., Kuner, R., & Geißlinger, G. (2015) · Der Schmerz · doi:10.1007/s00482-015-0042-0 · Cited by 2
2020 foresight: Envisioning therapeutic innovations for pain
Hamza, M., & Dionne, R. A. (2009) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2010.10.002 · Cited by 4
Neuropathische Schmerzen: Pathophysiologie, Diagnostik und Therapie
Sommer, C. (2013) · Der Schmerz · Cited by 3
Opretzka, L. C. F., de Freitas, H. F., Santo, R. F. D. E., Abreu, L. S., Alves, I. M., Tavares, J. F., Velozo, E. D. S., Castilho, M. S., & Villarreal, C. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073413 · Cited by 3
“On the other hand, substances that act on GABAergic pathways, chromones included, have shown preclinical efficacy on different types of neuropathy, making them a potential source of relief to these painful conditions [11,12,45,47,48].”
BackgroundSpinal plasticity of the nociceptive system
Latrémolière, A. (2016) · Wiley eBooks · doi:10.1002/9781118455968.ch2 · Cited by 4
Muscle relaxants for pain management in rheumatoid arthritis
Richards, B. L., Whittle, S., & Buchbinder, R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008922 · Cited by 3
Neuropathischer Schmerz: Der Weg zur Entschlüsselung der Blackbox
Maier, C., Baron, R., & Sommer, C. (2015) · Der Schmerz · doi:10.1007/s00482-015-0028-y · Cited by 9
Involvement of Spinal Neuroplastin 65 in Neuropathic Pain by GABAA Receptor α2 Subunit Regulation
Li, X., Wang, Y., Jiao, Y., Huang, Y., Xu, R. C., Gu, X., Zhang, W. Y., & Ma, Z. (2024) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006964 · Cited by 2
An afferent nerve-like electronic device with somatic mechanical perception and sensation management
Zhu, M. J., Luo, J., Zhang, B., Li, K., Li, Y., Zhang, Q., Wang, H., & Hou, C. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116625 · Cited by 2
Poslusney, M. S., Li, Q., Buchler, I. P., Huang, Y., Liu, L., Zhu, Y., Kulkarni, S., Carr, G. V., DeBrosse, A. C., White, N., et al. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101704 · Cited by 4
“11 Nevertheless, recent evidence supports a prominent role for peripheral GABRAs in mediating analgesia that appears to be distinct from their central effects.”
GABAergic and Glycinergic Inhibition in Pain Pathways
Zeilhofer, H. U., & Ganley, R. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.24133-3 · Cited by 2
Self-citationExtrasynaptic α5GABAA receptors and their role in nociception and pathological pain
Franco‐Enzástiga, Ú., la Luz-Cuellar, Y. E. D., Hernández-Reyes, L. E., Raya‐Tafolla, G., Torres‐López, J. E., Murbartián, J., Granados‐Soto, V., & Delgado‐Lezama, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820589-1.00012-9 · Cited by 2
GABAA receptors in GtoPdb v.2023.1
Belelli, D., Hales, T. G., Lambert, J. J., Lüscher, B., Olsen, R. W., Peters, J. A., Rudolph, U., & Sieghart, W. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f72/2023.1 · Cited by 6
Self-citationPakkhesal, S., Shakouri, M., Mosaddeghi-Heris, R., Kiani-Nasab, S., Salehi, N., Sharafi, A., & Ahmadalipour, A. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108799 · Cited by 5
Mechanisms of pain transmission and transduction
Gereau, R. W., & Cavallone, L. F. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781933.017 · Cited by 3
de la Roche, J., Buchholz, V., Dengler, R., Haeseler, G., Leuwer, M., & Ahrens, J. (2011) · Pharmacology · doi:10.1159/000323557 · Cited by 2
“The strychnine-sensitive glycine receptor (GlyR) is one major part of fast-inhibitory postsynaptic neurotransmission in the spinal cord, retina and brainstem. It is known to be involved in spinal motor rhythm responses and processing of sensory signals. In recent years, loss of inhibitory synaptic transmission within…”
BackgroundShehab, S. A. S., Rehmathulla, S., & Javed, H. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24509 · Cited by 2
GABAA receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Belelli, D., Hales, T. G., Lambert, J. J., Lüscher, B., Olsen, R. W., Peters, J. A., Rudolph, U., & Sieghart, W. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f72/2019.4 · Cited by 5
Self-citationExtrasynaptic GABAA Receptors and Tonic Inhibition in Spinal Cord
Loeza‐Alcocer, E., Andrés, C., Aguilar, J., Felix, R., & Delgado‐Lezama, R. (2014) · The Receptors · doi:10.1007/978-1-4939-1426-5_8 · Cited by 2
Cerne, R., Smith, J. L., Fisher, J. L., Golani, L. K., Knutson, D. E., Cook, J. M., & Witkin, J. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820589-1.00011-7 · Cited by 2
Feng, Y.-Q., Guo, N., Sun, Q.-S., Chen, X., Liu, J.-X., Lai, R., & Huang, F. (2012) · Journal of clinical neuroscience · doi:10.1016/j.jocn.2011.09.034 · Cited by 1
Braun, K., Mannewitz, A., Bock, J., Kreitz, S., Heß, A., Scheich, H., & Goldschmidt, J. (2021) · Brain Sciences · doi:10.3390/brainsci11050659 · Cited by 1
“Voxel-wise statistics were collected with the MagnAn-software (version 2.4, BioCom GbR, D-90180 Uttenreuth, Germany) [11,12].”
InfluentialDavis, O., Todd, A. J., & Price, T. J. (2025) · The Journal of Comparative Neurology · doi:10.1002/cne.70091 · Cited by 2
“…of the GABA A antagonist, bicuculine, has been shown to induce allodynia (Yaksh, 1989), whilst selective activation of spinal GABA A receptors containing the 2 receptor subunit has been shown to restore sensory thresholds in inflammatory and neuropathic pain rodent models (Knabl et al., 2008).”
Preclinical evidence for a novel pharmacotherapeutic approach for treating benzodiazepine addiction
Berro, L. F., Cook, J. E., Moreira-Junior, E. D. C., Hembree, H. L., Comfort, V. L., Rüedi‐Bettschen, D., Platt, D. M., & Rowlett, J. K. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03762-0 · Cited by 1
Neumann, E., Popa, M. O., Elvers, K. T., Oyama, M., Ulrich, D., Hanley, M., Feng, G. J., Hathaway, T., Ralvenius, W. T., Grampp, T., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70301 · Cited by 1
“…Potentiation of GABA A R currents in dorsal horn neurons of mice with peripheral nerve injury We have previously shown that non-selective (diazepam; Knabl et al., 2008) and subtype-selective (TPA023B; Ralvenius et al., 2018) BDZ site agonists potentiate GABA A R currents in dorsal horn neurons of…”
InfluentialSelf-citationFu, L., Xu, N., SHANG, J., YANG, Q., Li, Y., Huang, Q., Li, J., & Jiang, H. (2026) · Journal of Pain Research · doi:10.2147/jpr.s588472 · Cited by 1
“10,11 These subunits may reduce pain by limiting calcium influx, thereby decreasing the release of excitatory neurotransmitters like glutamate and norepinephrine.”
Iannone, L. F., Romozzi, M., Pani, L., & Tascedda, F. (2026) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2026.2687030 · Cited by 2
“…a role in the modulation of nociceptive transmission at both spinal and supraspinal levels. α2/α3-containing receptors are present in dorsal horn interneurons and descending inhibitory pathways, suggesting that their potentiation may reduce central sensitization and alter pain perception [22,23].”
Rudolph, U., Davies, M. F., & Barr, J. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781933.030 · Cited by 1
Self-citationPicking out the pieces of GABA receptors
Harrison, C. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2536 · Cited by 1
Synaptic Transmission of Pain in the Developing Spinal Cord
Ingram, R. A., Baccei, M. L., & Fitzgerald, M. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0226-9_4 · Cited by 1
“Two of these subunits, a2 and a3, are of particular interest in pain signalling pathways as their specific activation has recently been shown to significantly reduce both inflammatory and neuropathic pain in the absence of a1-mediated sedation (Knabl et al. 2008).”
BackgroundTargeting Cognitive Deficits in Schizophrenia via GABAA Receptors
Rudolph, U., & Möhler, H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801829-3.00017-3 · Cited by 1
Self-citationThe Role of Intravenous Agents in Delirium
Spies, C., Koch, S., Wolf, A., Mörgeli, R., & Weiß, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-47609-4_40 · Cited by 1
Disrupted synaptic gene expression in Fabry disease: Findings from RNA sequencing
López-Valverde, L., Vázquez-Mosquera, M. E., Colón, C., Álvarez, J. V., López-Pardo, B. M., López, L. L., Sánchez‐Martínez, R., Mendoza, M. L., Rodriguez, M. L., Villacorta, E., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106908 · Cited by 1
“The loss of synaptic inhibition contributes to pain pathology (Knabl et al., 2008), as observed in FD neuropathy (Weissmann et al., 2021), while extrasynaptic inhibition is involved in modulating cognitive functions such as learning and memory (Koh et al., 2023).”
Inquimbert, P., & Scholz, J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374947-5.00054-7 · Cited by 2
Golovenko, M. Y. (2021) · Clinical pharmacy · doi:10.24959/cphj.21.1541 · Cited by 1
A novel ENU-induced mutation, peewee, causes dwarfism in the mouse
Lee, B., Kanô, K., Young, J. A., John, S. W. M., Nishina, P. M., Naggert, J. Κ., & Naito, K. (2009) · Mammalian Genome · doi:10.1007/s00335-009-9197-2 · Cited by 3
“Gabra2 and Gabra4 are members of the GABA-A receptor family, and both of these knockout mice show mainly phenotypes of behavior (Chandra et al. 2006; Knabl et al. 2008).”
BackgroundLötsch, J. (2008) · Der Anaesthesist · doi:10.1007/s00101-008-1368-0
Ion Channels in Drug Discovery - focus on biological assays
Dekermendjian, K. (2008) · Figshare
Electrophysiological Markers for Neuropathic Pain in Spinal Cord Injured Subjects
Wydenkeller, S. (2009) · Zurich Open Repository and Archive (University of Zurich) · doi:10.3929/ethz-a-005773226
“Electrophysiological markers for Neuropathic Pain in SCI Subjects 10 be achieved by facilitation of GABAergic neurotransmission (Knabl et al., 2008).”
BackgroundPicking out the pieces of GABA receptors
Harrison, C. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2349
González‐Burgos, G., Fish, K. N., & Lewis, D. A. (2011)
specific GABA impairment for activation of descending pain facilitation
Zhang, Z., Wang, X., Wang, W., Lu, Y., & Pan, Z. Z. (2013)
Ingram, R. A., Baccei, M. L., & Fitzgerald, M. (2009) · UCL Discovery (University College London)
New Therapeutic Approach to Primary Stabbing Headache
Ngonga, G. K., Carli, D., Zavarise, P., Vollaro, S., & Volta, G. D. (2016) · OALib · doi:10.4236/oalib.1102529
“In mice and rats subtype-selective compounds targeting the alpha 2 and/or alpha 3 subunit of the GABAA receptor produce antihyperalgesia without sedation and without tolerance induction [15].”
BackgroundPeripheral mechanisms of touch and pain
Sexton, J. (2016) · UCL Discovery (University College London)
Curatolo, M., & Arendt‐Nielsen, L. (2015)
Mattioli, T.-A. M. (2013) · QSpace (Queen's University Library)
Metadata
- Authors
- Knabl, J., Witschi, R., Hösl, K., Reinold, H., Zeilhofer, U. B., Ahmadi, S., Brockhaus, J., Sergejeva, M., Hess, A., Brune, K., Fritschy, J.-M., Rudolph, U., Möhler, H., & Zeilhofer, H. U.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Zurich (CH)
- University of Bonn (DE)
- Harvard University (US)
- Corresponding author
- Zeilhofer, Hanns Ulrich
- Venue
- Nature
- Published
- 2008-01
- Volume
- 451
- Issue
- 7176
- Pages
- 330-334
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2011606970
- Cited by
- 438
- References
- 43
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 13 · 2023: 10 · 2022: 15 · 2021: 22 · 2020: 24 · 2019: 17 · 2018: 23 · 2017: 21 · 2016: 27 · 2015: 33 · 2014: 27 · 2013: 38 · 2012: 38
- FWCI
- 23.97
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Keywords
- chronic pain, neuropathic pain, inflammatory pain, GABAA receptor subtypes, alpha2 subunit, alpha3 subunit, synaptic inhibition, dorsal horn, GABAergic neurotransmission, knock-in mice, analgesia, sedation, tolerance (pharmacology and immunology), pain-related brain activity
- MeSH terms
- Analgesics, Animals, Brain, Capsaicin, Chronic Disease, Diazepam, Disease Models, Animal, Fluorobenzenes, Formaldehyde, Ganglia, Spinal, Hot Temperature, Inflammation, Male, Neurons, Organ Specificity, Pain, Receptors, GABA-A, Spinal Cord, Triazoles, Rats, Wistar, Protein Isoforms, Protein Subunits, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.